Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide

Inhibition of protein deacetylation enzymes, alone or in combination with standard chemotherapies, is an exciting addition to cancer therapy. We have investigated the effect of deacetylase inhibition on the metabolism of glioblastoma cells. 1H NMR metabolomics analysis was used to determine the majo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Miroslava Cuperlovic-Culf, Mohamed Touaibia, Patrick-Denis St-Coeur, Julie Poitras, Pier Morin, Adrian S. Culf
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2014-09-01
Collection:Metabolites
Sujets:
metaboloepigenomics
NMR metabolomics
glioblastoma
enzyme inhibitors
combined treatment
Accès en ligne:http://www.mdpi.com/2218-1989/4/3/807
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires